Dastagir, M. (2026). Impact of pleural effusion on mortality and hospitalization in stage IV EGFR -mutated NSCLC treated with osimertinib: A real-world analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20646